Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics
JAMA NEUROLOGY RELEASES HIGHLY PROMISING DATA FROM A CLINICAL TRIAL CONDUCTED BY HADASSAH MEDICAL ORGANIZATION JERUSALEM AND BRAINSTORM CELL THERAPEUTICS “In the clinical trial of intrathecal infusion of stem cells…
